Delivery Order SPE2DB22D1106-SPE2DB25FFGM8
- Not listed
- The Defense Logistics Agency awarded a $10,741.92 delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Phytonadione 1 mg/0.5 mL syringes in 0.5 mL quantities, with an ultimate completion date of August 14, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order is a child contract issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Phytonadione 1 mg/0.5 mL syringes with a ceiling value of $20,559.12. This firm fixed-price delivery order, with an ultimate completion date of July 25, 2025, represents a competitively awarded contract with no set-aside designation. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Phytonadione 1 mg/0.5 mL syringes with a ceiling value of $3,132.07 under firm fixed price terms. The delivery order is not set-aside and represents a competitively awarded procurement. This award is a child contract issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $2,454.71 on September 10, 2025, for the supply of Phytonadione 1 mg/0.5 mL syringes in 0.5 mL quantities. This firm fixed price, competitively awarded contract is a child order under the company's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The order will be performed at the contractor's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $8,308.92 to AmerisourceBergen Drug Corp for Phytonadione 1 mg/0.5 mL syringes on September 17, 2025, with completion targeted for September 18, 2025. The award was made on a firm fixed-price basis with no set-aside designation, indicating competitive selection. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Phytonadione 1 mg/0.5 mL syringes in 0.5 mL units, valued at $3,037.93. This is a firm fixed price delivery order with no set-aside designation, utilizing competitive procurement procedures. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 22, 2025. Phytonadione, commonly...
- The Defense Logistics Agency awarded a $55,089.27 delivery order to AmerisourceBergen Drug Corp for Phytonadione 1 mg/0.5 mL syringes on July 3, 2025, with an ultimate completion date of July 7, 2025. This is a firm fixed price, non-set-aside contract utilizing a competitively awarded delivery order model. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Phytonadione, commonly known as Vitamin K1, is a critical pharmaceutical product used...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 17, 2025, for the supply of Phytonadione 1 mg/0.5 mL syringes in 0.5 mL unit doses. This firm fixed-price delivery order, valued at $7,614.34, will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of June 18, 2025. The contract utilizes no set-aside designation and represents a competitive award under the contractor's existing indefinite delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,012.32 to AmerisourceBergen Drug Corp for Phytonadione 1 mg/0.5 mL syringes (0.5 mL units). This is a firm fixed-price delivery order with no set-aside designation, executed on July 31, 2025, with an ultimate completion date of August 1, 2025. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $2,333.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Phytonadione 1 mg/0.5 mL syringes in 0.5 mL unit doses. The contract, which is classified as a child order under a larger vehicle, carries an ultimate completion date of September 3, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was utilized for this competitive...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFGM8Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Phytonadione 1 mg/0.5 mL syringes valued at $47,007.95. This is a firm fixed-price delivery order with no set-aside designation, placing performance at the contractor's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of September 4, 2025. The award represents a competitive procurement under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion pharmaceutical prime vendor agreement running through December 2026 that enables the company to supply a comprehensive range of medications and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse pharmaceutical supply needs across multiple therapeutic domains through open competition. This delivery order for Phytonadione—a Vitamin K derivative used for blood clotting disorders and anticoagulant reversal—exemplifies the routine medical supply fulfillment the contractor provides to support Defense Health Agency and broader military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $47.0k | 9/3/25 |